Fusacq buzz x Dianosic
Discover our other articles
We are pleased to announce the closing of a €7 million financing round. This milestone marks a major step forward for Dianosic and further…
Dianosic launches a WiSEED backed convertible bonds transaction to accelerate innovation in the treatment of chronic allergic rhinitis. This initiative aims to support the…
Nov 19, 2025
Dianosic shortlisted for the “Trophées des Entreprises Alsace 2024” award
Awards
We are delighted to announce that Dianosic is one of the nominees for the 2024 edition of the “Trophées des entreprises d’Alsace”. This selection…
